Cost-effectiveness of Ezetimibe plus statin lipid-lowering therapy: A systematic review and meta-analysis of cost-utility studies
In addition to statin therapy, Ezetimibe, a non-statin lipid-modifying agent, is increasingly used to reduce low-density lipoprotein cholesterol and atherosclerotic cardiovascular disease risk. Literature suggests the clinical effectiveness of Ezetimibe plus statin (EPS) therapy; however, primary ev...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science (PLoS)
2022-01-01
|
| シリーズ: | PLoS ONE |
| オンライン･アクセス: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202874/?tool=EBI |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|